David Linetsky
Net Worth

Last updated:

What is David Linetsky net worth?

The estimated net worth of Mr. David Linetsky is at least $20,674,260 as of 18 Oct 2024. He owns shares worth $5,593,784 as insider, has earned $11,609,716 from insider trading and has received compensation worth at least $3,470,760 in Phreesia, Inc..

What is the salary of David Linetsky?

Mr. David Linetsky salary is $578,460 per year as Senior Vice President of Life Sciences in Phreesia, Inc..

How old is David Linetsky?

Mr. David Linetsky is 46 years old, born in 1979.

What stocks does David Linetsky currently own?

As insider, Mr. David Linetsky owns shares in one company:

Company Title Shares Price per share Total value
Phreesia, Inc. (PHR) Senior Vice President of Life Sciences 200,207 $27.94 $5,593,784

What does Phreesia, Inc. do?

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

David Linetsky insider trading

Phreesia, Inc.

Mr. David Linetsky has made 56 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,100 units of PHR stock worth $22,539 on 18 Oct 2024.

The largest trade he's ever made was exercising 50,060 units of PHR stock on 13 Mar 2020. As of 18 Oct 2024 he still owns at least 200,207 units of PHR stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,100 $20.49 $22,539
Sale
Common Stock 2,011 $21.03 $42,281
Sale
Common Stock 24 $24.04 $577
Sale
Common Stock 61 $24.09 $1,469
Sale
Common Stock 36 $24.77 $892
Sale
Common Stock 1,716 $23.25 $39,897
Sale
Common Stock 95 $23.25 $2,209
Sale
Common Stock 1,820 $23.74 $43,200
Sale
Common Stock 27 $20.24 $546
Sale
Common Stock 66 $19.73 $1,302
Sale
Common Stock 41 $19.2 $787
Sale
Common Stock 269 $22.85 $6,146
Sale
Common Stock 2,212 $22.86 $50,560
Sale
Common Stock 2 $23.02 $46
Sale
Common Stock 3,875 $22.62 $87,637
Sale
Common Stock 39 $23.02 $898
Sale
Common Stock 245 $22.62 $5,541
Sale
Common Stock 30 $23.66 $710
Sale
Common Stock 402 $23.27 $9,356
Sale
Common Stock 46 $22.22 $1,022
Sale
Common Stock 30,659 $24.12 $739,556
Sale
Common Stock 2,318 $24.55 $56,898
Sale
Common Stock 25 $23.72 $593
Sale
Common Stock 234 $23.15 $5,418
Sale
Common Stock 2,078 $16.61 $34,514
Sale
Common Stock 38 $19.71 $749
Sale
Common Stock 26 $19.79 $515
Sale
Common Stock 66 $19.59 $1,293
Sale
Common Stock 114 $20.3 $2,315
Sale
Common Stock 1,977 $20.3 $40,139
Sale
Common Stock 82 $21.21 $1,739
Sale
Common Stock 5 $21.21 $106
Option
Common Stock 5,689 $4.71 $26,795
Option
Stock Option 11,378 $6.37 $72,478
Option
Common Stock 475 $4.71 $2,237
Option
Common Stock 5,689 $8.03 $45,683
Sale
Common Stock 11,378 $39.55 $449,989
Sale
Common Stock 11,377 $34.61 $393,758
Sale
Common Stock 26,837 $29.78 $799,072
Option
Common Stock 30,950 $5.82 $180,036
Option
Stock Options (Right to buy) 6,636 $6.37 $42,271
Option
Common Stock 1,499 $4.71 $7,060
Sale
Common Stock 1,499 $75.12 $112,606
Option
Stock Option 4,977 $4.71 $23,442
Sale
Common Stock 3,478 $75.15 $261,382
Option
Common Stock 3,478 $4.71 $16,381
Sale
Common Stock 5,451 $70.83 $386,078
Option
Common Stock 5,451 $4.71 $25,674
Option
Stock Option 5,451 $4.71 $25,674
Sale
Common Stock 5,452 $65.36 $356,332
Option
Stock Option 5,452 $4.71 $25,679
Option
Common Stock 5,452 $4.71 $25,679
Sale
Common Stock 4,978 $70.56 $351,268
Option
Common Stock 4,978 $4.71 $23,446
Option
Stock Option 5,452 $4.71 $25,679
Sale
Common Stock 474 $71.84 $34,052
Option
Common Stock 474 $4.71 $2,233
Option
Common Stock 21,455 $2.55 $54,710
Option
Stock Option 21,455 $2.55 $54,710
Sale
Common Stock 21,455 $71.89 $1,542,443
Sale
Common Stock 800 $70.07 $56,054
Option
Common Stock 800 $70.07 $56,054
Option
Stock Option (Right to Buy) 800 $70.07 $56,054
Option
Stock Option (Right to Buy) 500 $2.55 $1,275
Option
Common Stock 500 $2.55 $1,275
Sale
Common Stock 500 $2.55 $1,275
Option
Stock Option 22,755 N/A N/A
Option
Common Stock 45,510 N/A N/A
Option
Common Stock 45,510 $2.03 $92,385
Sale
Common Stock 1,578 $60.15 $94,912
Sale
Common Stock 1,578 $60.15 $94,912
Sale
Common Stock 48,482 $30.85 $1,495,524
Sale
Common Stock 48,482 $61.38 $2,975,631
Sale
Common Stock 6,826 $33.07 $225,749
Sale
Common Stock 6,826 $65.5 $447,110
Sale
Common Stock 5,136 $64.28 $330,122
Option
Stock Option (Right to Buy) 1,377 N/A N/A
Option
Common Stock 1,377 N/A N/A
Sale
Common Stock 4,477 N/A N/A
Option
Common Stock 1,376 N/A N/A
Sale
Common Stock 4,475 N/A N/A
Option
Stock Option (Right to Buy) 1,376 N/A N/A
Sale
Common Stock 255 N/A N/A
Option
Common Stock 1,376 N/A N/A
Sale
Common Stock 4,220 N/A N/A
Option
Stock Option (Right to Buy) 1,376 N/A N/A
Option
Common Stock 50,060 $0.78 $39,197
Option
Common Stock 50,060 N/A N/A
Option
Stock Option (Right to Buy) 2,275 N/A N/A
Sale
Common Stock 3,188 N/A N/A
Option
Stock Option (Right to Buy) 3,413 N/A N/A
Option
Common Stock 6,826 N/A N/A

Phreesia key executives

Phreesia, Inc. executives and other stock owners filed with the SEC: